Executive General Manager, Customer Value
Meet Us at SCOPE Summit 2025
Be part of the future of clinical trials. At SCOPE Summit 2025, Medable is offering exclusive 1:1 meetings with our team of experts to explore how our award-winning digital platform can revolutionize your clinical operations.
Why Meet with Medable?
What’s in it for you?
- • Double Your Speed: See how Medable can cut trial startup times in half across therapeutic areas.
- • Go Global, Stay Seamless: Discover how we deliver compliant, clean data in 70+ countries and 120+ languages.
- • Scale Smarter: Transition from single studies to enterprise-wide programs with our innovative point-and-click Medable Studio.
- • Drive Patient Engagement: Learn how our real-time digital tools improve adherence, retention, and outcomes.
What’s in it for you?
- • Tailored Solutions: Walk away with actionable strategies to enhance your specific clinical programs.
- • Exclusive Insights: Be among the first to preview our newest capabilities that redefine speed, scale, and patient-centricity.
Rosen Shingle Creek, 9939 Universal Blvd, Orlando, FL 32819
February 3 - February 6
Book a 30 minute meeting
Schedule a brief introductory conversation at SCOPE Summit 2025 with our trial and technology experts.
Meet the Medable team
Schedule a meeting to talk with one of our clinical research and trial experts.
Chief Executive Officer
Michelle Longmire
Discuss your DCT and enterprise solutions for pharma and biotech.
Executive General Manager, Customer Value
Andrew Mackinnon
Discuss the ROI of Medable Studio, eConsent, and site adoption.
Chief Scientific Officer
Pamela Tenaerts
Discuss the ROI of Medable Studio, eConsent, and site adoption.
Chief Customer Officer
Alison Holland
Discuss eCOA strategy, current FDA Guidelines, and how to best plan for using eCOA in your trial.
Chief Revenue Officer
Dave Orrico
Discuss your DCT and enterprise solutions for pharma and biotech.
How Medable is making the Design, Configuration and Launch of Studies Easier, More Efficient and With Better Outcomes
Track: C9: Decentralized & Hybrid
Abstract:
Medable Studio is a fully featured SaaS suite of study design, configuration, translation and launch tools that enables easy and efficient study builds. In this presentation Medable, with a partner from a key customer, will talk about design best practice, how Studio has enabled faster study launch, and the adherence and satisfaction outcomes that have been observed in live studies.
- TBD
Wednesday, February 5
9:55 AM EST
30 minutes
FEB
5
Achieving Flexibility and Expanding Access While Preserving Data Quality
Track: C9 DCTs & Clinical Innovation
Moderator:
Lindsay Kehoe, Project Manager, Clinical Trials Transformation Initiative
Panelists:
Pamela Tenaerts, CSO, Medable
Wes Burian, Patient
Charmaine Demanuele, PhD, Executive Director, Head, Quantitative Sciences for Digital Sciences & Translational Imaging, Pfizer Inc.
Moderator:
Lindsay Kehoe, Project Manager, Clinical Trials Transformation Initiative
Panelists:
Pamela Tenaerts, CSO, Medable
Wes Burian, Patient
Charmaine Demanuele, PhD, Executive Director, Head, Quantitative Sciences for Digital Sciences & Translational Imaging, Pfizer Inc.
- TBD
- Thursday, February 6
- 12:25 PM EST
- 30 minutes
FEB
